[Myocardial metabolism, oxygen demand and oxygen supply during prostaglandin E1 induced hypotension]. 1994

H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
Department of Anesthesia, Fujisawa City Hospital.

The effects of hypotensive anesthesia induced by PGE1 on myocardial metabolism, oxygen demand and oxygen supply were studied. Nine mongrel dogs were anesthetized with pentobarbital and isoflurane. Mean blood pressure (MBP), cardiac output (CO), blood gases (BG), coronary blood flow (CBF), and myocardial tissue oxygen tension (MPO) were measured. Arterial and coronary venous lactate and pyruvate concentrations were also measured. We calculated myocardial oxygen consumption, L/P ratio, excess lactate, oxygen extraction ratio and lactate extraction ratio to estimate the adequacy of myocardial aerobic metabolism. CO and CBF decreased in accordance with MBP depression. Myocardial oxygen consumption decreased significantly with PGE1 administration. Lactate and pyruvate concentrations, L/P ratio, excess lactate and myocardial tissue oxygen tension were unchanged. These results suggest that PGE1 exerts no significant effect on myocardial metabolism during hypotensive anesthesia.

UI MeSH Term Description Entries
D007023 Hypotension, Controlled Procedure in which arterial blood pressure is intentionally reduced in order to control blood loss during surgery. This procedure is performed either pharmacologically or by pre-surgical removal of blood. Controlled Hypotension,Hypotension, Induced,Induced Hypotension
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
September 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
March 1980, Masui. The Japanese journal of anesthesiology,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
September 1990, Chest,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
January 1994, Advances in pharmacology (San Diego, Calif.),
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
September 1994, Prostaglandins, leukotrienes, and essential fatty acids,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
April 1994, British journal of anaesthesia,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
November 1993, Prostaglandins, leukotrienes, and essential fatty acids,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
April 1994, Prostaglandins, leukotrienes, and essential fatty acids,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
September 1991, Anesthesia and analgesia,
H Suzuki, and M Asada, and T Tateyama, and K Hashimoto, and K Okazaki, and Y Okutsu, and F Okumura
May 1992, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!